News Sentiment

PTX sentiment intelligence

Prescient Therapeutics Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 13 relevant articles
Exchange ASX Australia
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.07 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

90/100 classification confidence.

Company focus 13

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+5.9% over one week, +5.9% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Prescient Therapeutics (ASX:PTX) Jumps: Could Its Cancer-Therapy Pipeline Become the Next ASX Biotech Catalyst?

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 90/100 classification
One-week reaction 5.9% Price confirming higher
Trend fit Trend inactive 5.9% over four weeks
Fair value 31.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 11
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 13
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Kalkine Media 4
Kalkine 2
Proactive financial news 2
TipRanks 1
simplywall.st 1
smallcaps.com.au 1
The Australian 1
intelligentinvestor.com.au 1

Event Lens

What the news is about

Classified themes
Market update 11
Balance sheet 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-13 of 13